Xiaflex Approval History
FDA Approved: Yes (First approved February 3, 2010)
Brand name: Xiaflex
Generic name: collagenase clostridium histolyticum
Company: BioSpecifics Technologies Corp.
Treatment for: Dupuytren's Contracture
Xiaflex (collagenase clostridium histolyticum) is a collagenase product for the treatment of Dupuytren's contracture, a condition that affects the connective tissue that lies beneath the skin in the palm.
Development History and FDA Approval Process for Xiaflex
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.